171 related articles for article (PubMed ID: 36690931)
21. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
22. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
23. Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models.
Belhechmi S; Bin R; Rotolo F; Michiels S
BMC Bioinformatics; 2020 Jul; 21(1):277. PubMed ID: 32615919
[TBL] [Abstract][Full Text] [Related]
24. Incorporating covariates information in adaptive clinical trials for precision medicine.
Zhao W; Ma W; Wang F; Hu F
Pharm Stat; 2022 Jan; 21(1):176-195. PubMed ID: 34369053
[TBL] [Abstract][Full Text] [Related]
25. A plea for taking all available clinical information into account when assessing the predictive value of omics data.
Volkmann A; De Bin R; Sauerbrei W; Boulesteix AL
BMC Med Res Methodol; 2019 Jul; 19(1):162. PubMed ID: 31340753
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
27. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers.
Hambly N; Shimbori C; Kolb M
Respirology; 2015 Oct; 20(7):1010-22. PubMed ID: 26109466
[TBL] [Abstract][Full Text] [Related]
28. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
29. The role of genomics to identify biomarkers and signaling molecules during severe sepsis.
Douglas JJ; Roussel JA
Minerva Anestesiol; 2016 Mar; 82(3):343-58. PubMed ID: 26091010
[TBL] [Abstract][Full Text] [Related]
30. Regularized logistic regression with network-based pairwise interaction for biomarker identification in breast cancer.
Wu MY; Zhang XF; Dai DQ; Ou-Yang L; Zhu Y; Yan H
BMC Bioinformatics; 2016 Feb; 17():108. PubMed ID: 26921029
[TBL] [Abstract][Full Text] [Related]
31. Predictive biomarkers for systemic therapy of hepatocellular carcinoma.
Moldogazieva NT; Zavadskiy SP; Sologova SS; Mokhosoev IM; Terentiev AA
Expert Rev Mol Diagn; 2021 Nov; 21(11):1147-1164. PubMed ID: 34582293
[No Abstract] [Full Text] [Related]
32. Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review.
Lamy PJ; Allory Y; Gauchez AS; Asselain B; Beuzeboc P; de Cremoux P; Fontugne J; Georges A; Hennequin C; Lehmann-Che J; Massard C; Millet I; Murez T; Schlageter MH; Rouvière O; Kassab-Chahmi D; Rozet F; Descotes JL; Rébillard X
Eur Urol Focus; 2018 Dec; 4(6):790-803. PubMed ID: 28753865
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional Settings.
Gilhodes J; Dalenc F; Gal J; Zemmour C; Leconte E; Boher JM; Filleron T
Comput Math Methods Med; 2020; 2020():6795392. PubMed ID: 32670394
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
Zhan S; Li J; Wang T; Ge W
Oncologist; 2018 Dec; 23(12):1415-1425. PubMed ID: 29739896
[TBL] [Abstract][Full Text] [Related]
35. Predictive and prognostic cancer biomarkers revisited.
Pritzker KP
Expert Rev Mol Diagn; 2015; 15(8):971-4. PubMed ID: 26134385
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review.
Rebuzzi SE; Perrone F; Bersanelli M; Bregni G; Milella M; Buti S
Expert Rev Mol Diagn; 2020 Feb; 20(2):169-185. PubMed ID: 31608727
[No Abstract] [Full Text] [Related]
37. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.
Olsen L; Campos B; Winther O; Sgroi DC; Karger BL; Brusic V
BMC Med Genomics; 2014; 7 Suppl 3(Suppl 3):S2. PubMed ID: 25521819
[TBL] [Abstract][Full Text] [Related]
38. Proteomics biomarkers for solid tumors: Current status and future prospects.
Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer proteomics: a review for clinicians.
Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
Tejpar S; Bertagnolli M; Bosman F; Lenz HJ; Garraway L; Waldman F; Warren R; Bild A; Collins-Brennan D; Hahn H; Harkin DP; Kennedy R; Ilyas M; Morreau H; Proutski V; Swanton C; Tomlinson I; Delorenzi M; Fiocca R; Van Cutsem E; Roth A
Oncologist; 2010; 15(4):390-404. PubMed ID: 20350999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
